M12 (M12) News
Track canonical SquawkNews coverage tagged to M12, M12. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
M1 Kliniken: Beauty growth lifts margins as trading exit completes
M1 Kliniken says its Beauty segment delivered double-digit revenue and EBIT growth, while the trading segment was exited after selling HAEMATO Pharm GmbH. Group EBIT margin improved significantly; targets EUR 200–300 mil
EARNINGS | Sep 09, 2026, 06:45 AM UTC
L
Aesthetic clinic operator M1 Kliniken H1 revenue falls as HAEMATO Pharm disposal cuts trading sales
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Sep 09, 2026, 06:43 AM UTC
L
M1 Kliniken margins and profitability surge after strategic realignment
M1 Kliniken’s refocus on aesthetic medicine cut group sales but lifted margins and profitability. The Beauty segment grew double digits with improved EBIT, while equity and liquidity strengthened. A EUR 1.20 dividend per
EARNINGS | Sep 09, 2026, 06:35 AM UTC
L
StarHub seen as only viable local buyer for M1: Citi note
Citi analyst Arthur Pineda says StarHub is likely the only viable local buyer for M1 if Keppel is willing to sell after SIMBA’s cancelled bid. M1 pricing would likely need revision lower from SIMBA’s S$1.43 billion offer
EQUITY | Sep 09, 2026, 05:32 AM UTC